GlaxoSmithKline PLC (NYSE:GSK)

40.55
Delayed Data
As of Feb 22
 0.00 / 0.00%
Today’s Change
35.78
Today|||52-Week Range
42.36
+6.12%
Year-to-Date
GSK Regular Dividend: GSK began trading ex-dividend on 02/21/19. A $0.597 dividend will be paid to shareholders of record as of 02/22/19.
Emergent (EBS) Q4 Earnings, Revenues Surpass Estimates
Feb 22 / Zacks.com - Paid Partner Content
Novo Nordisk Gets FDA Nod for Haemophilia Drug Esperoct
Feb 20 / Zacks.com - Paid Partner Content
Top Ranked Income Stocks to Buy for February 22nd
Feb 22 / Zacks.com - Paid Partner Content
Bayer Obtains Full Rights to Vitrakvi From Lilly's Loxo
Feb 19 / Zacks.com - Paid Partner Content
Bausch (BHC) Q4 Earnings Beat Estimates, Revenues Down Y/Y
Feb 21 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for February 19th
Feb 19 / Zacks.com - Paid Partner Content
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
Feb 21 / Zacks.com - Paid Partner Content
Novartis Positioned to Be World's Top Drug Seller in 2024
Feb 18 / GuruFocus News - Paid Partner Content
Merck Gets Priority Review for Keytruda in Third-Line SCLC
Feb 21 / Zacks.com - Paid Partner Content
Top Ranked Growth Stocks to Buy for February 15th
Feb 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close40.55
Today’s open40.20
Day’s range40.15 - 40.66
Volume2,279,847
Average volume (3 months)3,610,314
Market cap$102.5B
Data as of 4:02pm ET, 02/22/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)+3.85%
Revenue growth (last year)+5.72%
P/E ratio41.5
Price/Sales2.31
Price/Book18.30

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.51+1.26%
SNYSanofi0.000.00%
LLYEli Lilly and Co0.000.00%
BMYBristol-Myers Squibb+0.85+1.70%
Data as of 4:00pm ET, 02/22/2019

Financials

Next reporting dateApril 24, 2019
EPS forecast (this quarter)$0.74
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Paul Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts